Reaktion #41129

ord-1a91fb6fdb434107a50d6b21eddb5fad

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturHeating
  2. 2
    Sonstigeunder microwave irradiation
  3. 3
    Sonstigeprovided
  4. 4
    Sonstigeafter purification by reverse phase HPLC, 1-tert-butyl-5-piperidin-1-yl-1H-pyrazole-4-carboxylic acid adamantan-2-ylamide (14 mg, 16%) as an white solid

Vorschrift

Heating a mixture of 1-tert-butyl-5-chloro-1H-pyrazole-4-carboxylic acid adamantan-2-ylamide (100 mg; 0.30 mmol) and pyrrolidine (0.25 mL; 3.0 mmol) under microwave irradiation according to the procedure described in Example 37, Step 5 provided after purification by reverse phase HPLC, 1-tert-butyl-5-piperidin-1-yl-1H-pyrazole-4-carboxylic acid adamantan-2-ylamide (14 mg, 16%) as an white solid. ES-HRMS m/e calcd for C22H34N4O (M+H+) 371.2806, found 371.2801.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07728029B2uspto-grants-2010_06